The US Food and Drug Administration (FDA) has accepted Bristol Myers Squibb’s (BMS) supplemental biologics licence ...
Keytruda demonstrated a statistically significant and clinically meaningful improvement in event-free survival and major ...
Merck (MRK) announced the FDA has accepted for priority review a new supplemental Biologics License Application seeking approval for keytruda – ...
Simplilearn, a global leader in digital upskilling, is excited to announce the appointment of Shane Clem as Vice President of ...
NeoVolta Inc. ("NeoVolta"), a leading innovator in energy storage solutions, announced today that it has completed phase two of its loan application for $300M from the U.S. Department of Energy (DOE) ...
The vaccine contract manufacturing market is expanding rapidly, driven by rising global demand for immunization and a growing emphasis on preventive ...